APA

Noël C., Abramowicz D., Durand D., Mourad G., Lang P., Kessler M., Charpentier B., Touchard G., Berthoux F., Merville P., Ouali N., Squifflet J., Bayle F., Wissing K. M. & Hazzan M. (20090630). Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. : Journal of the American Society of Nephrology : JASN.

Chicago

Noël Christian, Abramowicz Daniel, Durand Dominique, Mourad Georges, Lang Philippe, Kessler Michèle, Charpentier Bernard, Touchard Guy, Berthoux François, Merville Pierre, Ouali Nacera, Squifflet Jean-Paul, Bayle François, Wissing Karl Martin and Hazzan Marc. 20090630. Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. : Journal of the American Society of Nephrology : JASN.

Harvard

Noël C., Abramowicz D., Durand D., Mourad G., Lang P., Kessler M., Charpentier B., Touchard G., Berthoux F., Merville P., Ouali N., Squifflet J., Bayle F., Wissing K. M. and Hazzan M. (20090630). Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. : Journal of the American Society of Nephrology : JASN.

MLA

Noël Christian, Abramowicz Daniel, Durand Dominique, Mourad Georges, Lang Philippe, Kessler Michèle, Charpentier Bernard, Touchard Guy, Berthoux François, Merville Pierre, Ouali Nacera, Squifflet Jean-Paul, Bayle François, Wissing Karl Martin and Hazzan Marc. Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. : Journal of the American Society of Nephrology : JASN. 20090630.